Direxion Pharma & Medical Bull 3X
PILL19.7351.15% ( +0.225 )
Direxion Pharma & Medical Bull 3X (PILL)
PILL provides 3x daily exposure to a modified equal-weighted index of pharmaceutical companies in the US.
- Open
- 19.610
- High
- 19.990
- Low
- 19.260
- Prev. Close
- 19.510
- Volume
- 12.46K
- Turnover
- 245.50K
- Avg Price
- 19.711
- Bid/Ask Ratio
- --
- Amplitude
- 3.74%
- 52wk High
- 21.030
- Volume Ratio
- 0.77
- Turnover Ratio
- 1.19%
News
- prnewswire · 2 hours ago
09:25 ETPOZITÍVNE STANOVISKO VÝBORU PRE LIEKY NA HUMÁNNE POUŽITIE PODPORUJE ŠIRŠIE POUŽÍVANIE LIEKU REPATHA® OD SPOLOČNOSTI AMGEN PRED PRVÝM INFARKTOM ALEBO MOZGOVOU PRÍHODOU
- PUBT · 3 hours ago
J&J’s Rybrevant Faspro wins FDA priority review for advanced head and neck cancer treatment
- StockTitan · 1 day ago, 08:42 AM
Johnson & Johnson Completes Acquisition of Firefly Bio, Inc. to Advance Next-Generation Oncology Innovation | JNJ Stock News
- Simplywall · 1 day ago, 06:30 AM
The Bull Case For AbbVie (ABBV) Could Change Following EU Approval Of Rinvoq For Vitiligo
- PUBT · 1 day ago, 08:02 AM
Amgen says EU CHMP backs broader Repatha use to cut first heart attack, stroke risk
- StockTitan · 1 day ago, 06:00 PM
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia Areata | ABBV Stock News
